New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)

Article Editorial

Rational Pharmacotherapy in Cardiology
Racionalʹnaâ farmakoterapiâ v kardiologii

eng | рус

User

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Rational Pharmacotherapy in Cardiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer). Rational Pharmacotherapy in Cardiology. 2016;12(4):487-488. (In Russ.)

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Username
Password
	Remember me

User

Rational Pharmacotherapy in Cardiology

For citations:

Cookies policy